Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019029617) USE OF CD14 ANTAGONISTS FOR TREATING CANCER
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2019/029617 International Application No.: PCT/CN2018/099617
Publication Date: 14.02.2019 International Filing Date: 09.08.2018
IPC:
A61K 39/395 (2006.01) ,A61P 35/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
395
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
Applicants:
CHEN, Huei-Wen [CN/CN]; CN
Inventors:
CHEN, Huei-Wen; CN
YANG, Pan-Chyr; CN
CHEN, Wan-Jiun; CN
Agent:
DRAGON INTELLECTUAL PROPERTY LAW FIRM; 10F, Bldg. 2, Maples International Center No. 32 Xizhimen North Street, Haidian District Beijing 100082, CN
Priority Data:
62/543,06709.08.2017US
Title (EN) USE OF CD14 ANTAGONISTS FOR TREATING CANCER
(FR) UTILISATION D'ANTAGONISTES DE CD14 POUR LE TRAITEMENT DU CANCER
Abstract:
(EN) Methods for treating cancer and/or reducing stemness of cancer stem cells in a subject using a CD14 antagonist, which may be an anti-CD14 antibody.
(FR) L'invention concerne des procédés de traitement du cancer et/ou de réduction du caractère souche de cellules souches cancéreuses chez un sujet à l'aide d'un antagoniste de CD14, qui peut être un anticorps anti-CD14.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)